Long-term cyclosporin A pharmacokinetic profiles in pediatric renal transplant recipients

被引:0
作者
Kelles, A [1 ]
VanDammeLombaerts, R [1 ]
TjandraMaga, TB [1 ]
VanDamme, B [1 ]
机构
[1] UNIV HOSP GASTHUISBERG, DEPT PEDIAT NEPHROL, B-3000 LOUVAIN, BELGIUM
关键词
cyclosporin A; renal transplantation; children; CyA; pediatric; pharmacokinetics;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
To study the long-term effect of cyclosporin A (CyA), 94 6-h and 29 12-h pharmacokinetic profiles were evaluated in 32 children at least 1 year after renal transplantation. Children weighing less than 25 kg needed significantly higher doses of CyA than those weighing more than 25 kg(9.8 vs 5.3 mg/kg per day; P < 0.001) to achieve similar trough levels (TL). The average dose of CyA required to achieve the target TL declined gradually with time after transplantation. The average area under the curve over 6 h (AUC/6) correlated strongly with the AUC/12 (r = 0.967, P < 0.001). The AUC/6 of patients with biopsy-proven CyA toxicity was significantly higher than for those without, toxicity (Mann-Whitney U-test P < 0.05) despite similar TL. We conclude that AUC monitoring for 6 h provides valuable information not only on TL but also on the absorption and elimination characteristics of CyA as well as on the potential for CyA toxicity.
引用
收藏
页码:546 / 550
页数:5
相关论文
共 25 条
[11]   4 YEARS EXPERIENCE WITH CYCLOSPORINE-A IN PEDIATRIC KIDNEY-TRANSPLANTATION [J].
HOYER, PF ;
OFFNER, G ;
OEMAR, BS ;
BRODEHL, J ;
RINGE, B ;
PICHLMAYR, R .
ACTA PAEDIATRICA SCANDINAVICA, 1990, 79 (6-7) :622-629
[12]   PARENT-TO-CHILD TRANSPLANTATION WITH CYCLOSPORINE IMMUNOSUPPRESSION [J].
KAHAN, BD ;
CONLEY, S ;
PORTMAN, R ;
LEMAIRE, R ;
WIDEMAN, C ;
FLECHNER, S ;
VANBUREN, C .
JOURNAL OF PEDIATRICS, 1987, 111 (06) :1012-1016
[13]  
KAHAN BD, 1983, TRANSPLANT P, V15, P446
[14]  
KLARE B, 1984, LANCET, V2, P692
[15]   CYCLOSPORINE PLASMA-LEVELS IN RENAL-TRANSPLANT PATIENTS - ASSOCIATION WITH RENAL TOXICITY AND ALLOGRAFT-REJECTION [J].
KLINTMALM, G ;
SAWE, J ;
RINGDEN, O ;
VONBAHR, C ;
MAGNUSSON, A .
TRANSPLANTATION, 1985, 39 (02) :132-137
[16]   INFLUENCE OF CYCLOSPORINE PHARMACOKINETICS, TROUGH CONCENTRATIONS, AND AUC MONITORING ON OUTCOME AFTER KIDNEY-TRANSPLANTATION [J].
LINDHOLM, A ;
KAHAN, BD .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 54 (02) :205-218
[17]  
MASRI MA, 1992, TRANSPLANT P, V24, P1718
[18]  
MIHATSCH MJ, 1994, CLIN NEPHROL, V41, P23
[19]  
NEIBERGER R, 1987, TRANSPLANT P, V19, P1525
[20]  
PLANT ND, 1994, TRANSPLANT P, V26, P85